Gavi, UNICEF, and the WHO restart preventive cholera vaccination campaigns after a three-year pause, enabled by a restored global vaccine supply. The milestone follows collaborative efforts to stabilize production and distribution networks. Campaigns now target high-risk populations in regions facing cholera outbreaks.
The World Health Organization (WHO) approves an updated version of a cholera vaccine to combat rising cases, which have drained global vaccine supplies and strained poorer nations' epidemic response efforts. The revised vaccine aims to bolster stockpiles amid growing demand. The move follows a critical shortage linked to increased cholera outbreaks worldwide.
Gavi, the Vaccine Alliance, and UNICEF have endorsed the WHO approval of **Euvichol-S**, a new oral cholera vaccine. The vaccine expands global access to cholera prevention tools, complementing existing efforts to combat the disease. The organizations highlight its potential to strengthen public health responses in high-risk regions.
The World Health Organization (WHO) prequalifies **Euvichol-S**, an inactivated oral cholera vaccine with a simplified formulation. The vaccine matches the efficacy of existing options but enables faster production scaling. WHO’s approval supports broader cholera vaccination efforts globally.
